Course of intraocular pressure (IOP) and visual fields in patients with elevated IOPs treated for Graves’ orbitopathy (GO) with steroids, or orbital decompression, or inferior rectus muscle recession (n=9)
| Patient no (age (years)) | Sex | IOP (mm Hg) R/L before glaucoma therapy | IOP (mm Hg) R/L before GO therapy, (medication) | Optic disc | Visual fields | Therapy for GO | Indication for therapy | IOP (mm Hg) R/L >3 months after GO therapy | Visual fields after GO therapy |
|---|---|---|---|---|---|---|---|---|---|
| 5 (68) | F | 28/28 | 26/26, (timolol, pilocarpine) | normal | Both eyes: concentric defects | steroids IV | DON | 23/23, timolol, pilocarpine | normal |
| 6 (42) | F | 25/25 | 21/21, (timolol) | oedema | Both eyes: arcual defects | steroids IV | DON | 15/16 | normal |
| 7 (65) | F | 25/31 | 28/26, (timolol) | oedema | Both eyes: nerve fibre bundle scotoma | 3 wall orbital decompression | DON | 14/15, timolol | normal |
| 8 (73) | F | 27/27 | 24/24, (timolol) | normal | Both eyes: peripheral defects | 3 wall orbital decompression | DON | 15/17 | normal |
| 9 (42) | M | 25/28 | 20/17, (timolol) | normal | normal | 3 wall orbital decompression | rehabilitative | 14/14, timolol | normal |
| 10 (23) | F | 24/24 | 21/21, (timolol) | normal | normal | 3 wall orbital decompression | rehabilitative | 17/17 | normal |
| 11 (54) | F | 24/26 | 22/20, (timolol) | normal | normal | 2 wall orbital decompression | rehabilitative | 18/16 | normal |
| 12 (48) | F | 25/22 | 25/22, betaxolol | normal | normal | Both eyes: inferior rectus muscle recession | diplopia | 14/14 | normal |
| 13 (48) | F | 36/41 | 33/33, timolol, pilocarpine | normal | normal | Both eyes: inferior rectus muscle recession | high IOP | 18/18, timolol | normal |
DON=dysthyroid optic neuropathy.